DeGroot AP, Luyken R, Pikaar NA. Cholesterollowering effect of rolled oats. Lancet . 1963;;2:303-304.
Anderson JW, Gustafson NJ. Hypocholesterolemic effects of oat and bean products. Am J Clin Nutr . 1988;;48:749-753.
Kirby RW, Anderson JW, Sieling B, et al. Oatbran intake selectively lowers serum low-density lipoprotein cholesterol concentrations. Am J Clin Nutr . 1981;;34:824-829.
Anderson JW, Story L, Sieling B, Chen W-JL. Hypocholesterolemic effects of high-fiber diets rich in water-soluble plant fibers: long-term studies with oat-bran and bean-supplemented diets for hypercholesterolemic men. J Can Diet Assoc . 1984;;45:140-149.
Anderson JW, Siesel AE. Hypocholesterolemic effects of oat products. In: Furda I, Brine CJ, eds. New Developments in Dietary Fiber . New York, NY: Plenum Press; 1990;:17-36.
Anderson JW, Gilinsky NH, Deakins DA, et al. Lipid responses of hypercholesterolemic men to oatbran and wheat-bran intake. Am J Clin Nutr . 1991;; 54:678-683.
Van Horn LV, Liu K, Parker D, et al. Serum lipid response to oat product intake with a fat modified diet. J Am Diet Assoc . 1986;;86:377-386.
Van Horn LV, Emidy LA, Liu K, et al. Serum lipid response to a fat-modified, oatmeal-enhanced diet. Prev Med . 1988;;17:759-764.
Van Horn LV, Moag-Stahlberg A, Liu K, et al. Effects on serum lipids of adding instant oats to usual American diets. Am J Public Health . 1991;;81:183-187.
Keenan JM, Wenz JB, Myers S, Ripsin CM, Huang Z. Randomized controlled crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract . 1991;;33:600-608.
Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB. The hypocholesterolemic effects of β-glucan in oatmeal and oat bran: a dosecontrolled study. JAMA . 1991;;265:1833-1839.
Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med . 1990;;322:147-152.
O'Kell RT, Duston AA. Lack of effect of dietary oats on serum cholesterol. Mo Med . 1988;;85:72-78.
Stewart LM, Welch RW. The effects of dietary oatcakes on blood cholesterol and other factors in healthy free-living adults. J Hum Nutr Diet . 1990;;3: 436-437.
Demark-Wahnefried W, Bowering J, Cohen PS. Reduced serum cholesterol with dietary change using fat-modified and oat bran supplemented diets. J Am Diet Assoc . 1990;;90:223-229.
O'Brien LT, Barnard J, Hall JA, Pritikin N. Effects of a high-complex carbohydrate low cholesterol diet plus bran supplement on serum lipids. J Appl Nutr . 1985;;37:26-35.
Hegsted M, Windhauser MM, Lester SB, Morris SK. Stabilized rice bran and oat bran lower cholesterol in humans. FASEB J . 1989;:A368.
Storch K, Anderson JW, Young VR. Oat bran muffins lower serum cholesterol of healthy young people. Clin Res . 1984;;32:740A.
Welch RW, McVeigh AM, Murphy C. Hypocholesterolemic and other responses to oat bran intake in human subjects. Proc Nutr Soc . 1990;;49:50A.
Reynolds HR, Lindake BS, Hunninghake DB. Effect of oat bran on serum lipids. J Am Diet Assoc . 1989;;89:A112.
Gold KV, Davidson DM. Oat bran as a cholesterol-reducing dietary adjunct in a young, healthy population. West J Med . 1988;;148:299-302.
Kestin M, Moss R, Clifton PM, Nestel PJ. Comparative effects of three cereal brans on plasma lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin Nutr . 1990;;52: 661-666.
Turnbull WH, Leeds AR. The effect of rolled oats and a reduced/modified fat diet on apolipoproteins Al and B. J Clin Nutr Gastroenterol . 1989;;1:15-19.
McMichael AJ, Potter JD. Do intrinsic sex differences in lower alimentary tract physiology influence the sex-specific risks of bowel cancer and other biliary and intestinal diseases? Am J Epidemiol . 1983;; 118:620-627.
Turnbull WH, Leeds AR. Reduction of total and LDL-C cholesterol in plasma by oats. J Clin Nutr Gastroenterol . 1987;;2:177-181.
Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet, I-IV. Metabolism . 1965;;14:747-787.
Anderson JT, Jacobs DR Jr, Foster N, et al. Scoring systems for evaluating dietary pattern effect on serum cholesterol. Prev Med . 1979;;8:525-537.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials . 1986;;7:177-189.
Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates in clinical trials. Stat Med . 1989;;8:141-151.
SAS/STAT User's Guide . Release 6.03 edition. Cary, NC: SAS Institute Inc; 1988;.
Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med . 1987;;316:450-455.
Yach D. Meta-analysis in epidemiology. S Afr J Med . 1990;;78:94-97.
Oakes M. Statistical Inference . Chestnut Hill, Mass: Epidemiology Resources Inc; 1986;:157-159.
Thacker SB. Meta-analysis: a quantitative approach to research integration. JAMA . 1988;;259: 1685-1689.
Irwig L, Glasziou P, Wilson A, Macaskill P. Estimating an individual's true cholesterol level and response to intervention. JAMA . 1991;;266:1678-1685.
Clifton PM, Kestin M, Abbey M, Drysdale M, Nestel PJ. Relationship between sensitivity to dietary fat and dietary cholesterol. Arterioscler Thromb . 1990;;10:394-401.
Physiological Effects and Health Consequences of Dietary Fiber . Bethesda, Md: Life Science Research Office, Federation of American Societies for Experimental Biology; 1987;. Contract 223-84-2059.
Topping DL, Illman RJ, Dowling K, Trimble RP. Mechanisms whereby fibre could lower plasma cholesterol. In: Southgate DAT, Waldron K, Johnson IT, Fenwick GR. Dietary Fibre: Chemical and Biological Aspects . Cambridge, England: Royal Society of Chemistry; 1990;:300-304.
Slavin JL. Dietary fiber: classification, chemical analyses, and food sources. J Am Diet Assoc . 1987;;87: 1164-1171.
Welch RW, Leggett JM, Lloyd JD. Variation in the kernel (1—>3)(1—>4)-β-D-glucan content of oat cultivars and wild Avena species and its relationship to other characteristics. J Cereal Sci . 1991;;13:173-178.
Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results, I: reduction in incidence of coronary heart disease. JAMA . 1984;;251:351-364.
Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA . 1984;;251:365-374.